Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B17 | O75795 | 2/20 | 0.64 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | PDE9A | O76083 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | DRD1 | P21728 | 2/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6799194 | 0.78 | UGT2B17 (1.00) | UGT2B17SIGMAR1KDM4CPSMB5 | |
| SCHEMBL5272877 | 0.74 | UGT2B17 (0.62) | UGT2B17SIGMAR1KDM4CHRH3PSMB5 | |
| SCHEMBL703510 | 0.74 | UGT2B17 (0.62) | UGT2B17SIGMAR1KDM4CHRH3PSMB5 | |
| SCHEMBL30831935 | 0.74 | UGT2B17 (0.62) | UGT2B17SIGMAR1KDM4CHRH3PSMB5 | |
| SCHEMBL26294455 | 0.74 | UGT2B17 (0.38) | UGT2B17 | |
| Hydrochloric Acid SCHEMBL1976240 | 0.73 | UGT2B17 (0.61) | UGT2B17SIGMAR1KDM4CPSMB5 | |
| SCHEMBL24593611 | 0.72 | UGT2B17 (0.33) | UGT2B17PDE9A | |
| SCHEMBL1508636 | 0.72 | UGT2B17 (0.82) | UGT2B17SIGMAR1KDM4CDRD2DRD1 | |
| SCHEMBL15287102 | 0.70 | UGT2B17 (0.57) | UGT2B17SIGMAR1KDM4CDRD2DRD1 | |
| SCHEMBL15286569 | 0.70 | UGT2B17 (0.62) | UGT2B17SIGMAR1KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11268952-B2 | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof | FIRMENICH INCORPORATED (US) | 2022-03-08 | — | — | US | disclosed |
| US-20200225217-A1 | NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF | FIRMENICH INCORPORATED (US) | 2020-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200225217-A1 | NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF | TAS1R2, TAS1R1, TAS2R40 | UGT2B17 2870/4885SIGMAR1 231/4885PDE9A 1545/4885 |
| US-11268952-B2 | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof | TAS2R40, TAS1R2, TAS1R1 | UGT2B17 3050/4885SIGMAR1 237/4885PDE9A 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.